Psychoneuroendocrine interventions aimed at attenuating immunosenescence:A review by Bauer, Moisés E et al.
        
Citation for published version:
Bauer, ME, Muller, GC, Correa, BL, Vianna, P, Turner, JE & Bosch, JA 2013, 'Psychoneuroendocrine









The final publication is available at Springer via http://dx.doi.org/10.1007/s10522-012-9412-5
University of Bath
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 13. May. 2019
1	  	  
Published	  in	  Biogerontology,	  2013	  
 
PSYCHONEUROENDOCRINE	  INTERVENTIONS	  AIMED	  AT	  
ATTENUATING	  IMMUNOSENESCENCE	  –	  A	  REVIEW	  
Moisés	  E.	  Bauer	  a,	  Guilherme	  C.	  Muller	  a,b,	  Bruna	  Luz	  Correa	  a,	  Priscila	  Vianna	  c,	  	  
James	  E.	  Turner	  	  d	  and	  Jos	  A.	  Bosch	  e	  	  
	  
a	  Laboratory	  of	  Immunosenescence,	  Institute	  of	  Biomedical	  Research,	  	  Pontifical	  Catho-­‐
lic	  University	  of	  Rio	  Grande	  do	  Sul	  (PUCRS),	  Porto	  Alegre,	  Brazil.	  
	  
b	  Universidade	  do	  Vale	  do	  Rio	  dos	  Sinos	  (UNISINOS),	  São	  Leopoldo,	  Rio	  Grande	  do	  Sul,	  
Brazil.	  
	  
c	  Laboratory	  of	  Immunogenetics,	  Department	  of	  Genetics,	  Federal	  University	  of	  Rio	  
Grande	  do	  Sul	  (UFRGS),	  Porto	  Alegre,	  Brazil.	  
	  
d	  School	  of	  Cancer	  Sciences,	  University	  of	  Birmingham,	  Edgbaston,	  Birmingham,	  B15	  
2TT,	  UK	  
	  
e	  School	  of	  Sport	  and	  Exercise	  Sciences,	  University	  of	  Birmingham,	  Edgbaston,	  Birming-­‐
ham,	  B15	  2TT,	  UK.	  
	  
Keywords:	  aging,	  immunosenescence,	  glucocorticoids,	  lymphocytes	  
	  
Corresponding	  author:	  Dr.	  Moisés	  E.	  Bauer,	  Faculty	  of	  Biosciences,	  Instituto	  de	  Pesqui-­‐
sas	  Biomédicas,	  Pontifícia	  Universidade	  Católica	  do	  Rio	  Grande	  do	  Sul	  (PUCRS),	  Av.	  
Ipiranga	  6690,	  2º	  andar.	  P.O.	  Box	  1429.	  Porto	  Alegre,	  RS	  90.610-­‐000,	  Brazil.	  	  
mebauer@pucrs.br	  	  
	  	  	   	  
2	  	  
Abstract	  There	  is	  evidence	  suggesting	  that	  immunosenescence	  can	  be	  accelerated	  by	  exter-­‐nal	  factors	  such	  as	  chronic	  stress.	  Here	  we	  review	  potential	  psychoneuroendocrine	  determinants	  of	  premature	  aging	  of	  the	   immune	  system	  and	  discuss	  available	   in-­‐terventions	  aimed	  at	  attenuating	  immunosenescence.	  Chronic	  stress	  may	  acceler-­‐ate	   various	   features	   of	   immunosenescence	   by	   activating	   key	   allostatic	   systems,	  notably	   the	   hypothalamic-­‐pituitary-­‐adrenal	   axis.	   The	   immunological	   impact	   of	  such	  neuroendocrine	  dysregulation	  may	  be	  further	  amplified	  by	  a	  dramatic	  decline	  in	  dehydroepiandrosterone	  (DHEA)	  levels,	  acting	  in	  part	  as	  an	  endogenous	  gluco-­‐corticoid	  antagonist.	  Stress-­‐buffering	  strategies	  show	  beneficial	  effects	  on	  various	  biomarkers	  in	  elderly	  populations.	  Likewise,	  supplementation	  of	  DHEA,	  melatonin	  or	  growth	  hormone	  has	  yielded	  significant	  beneficial	  effects	  in	  a	  number	  of	  studies,	  including:	   increased	  well-­‐being,	  memory	  performance,	   bone	  mineral	   density	   and	  improved	  immunocompetence	  as	  evidenced	  by	  results	  of	  in	  vitro	  (T-­‐cell	  prolifera-­‐tion,	  cytotoxicity,	  cytokine	  production),	  and	   in	  vivo	   immune	  challenges.	  However,	  the	  side-­‐effects	  of	  hormonal	  supplementation	  are	  also	  discussed.	  Finally,	  moderate	  exercise	  via	   the	  promotion	  of	  cortisol/DHEA	  balance	  or	  epigenetic	  modifications,	  is	  associated	  with	  lower	  serum	  pro-­‐inflammatory	  cytokines,	  greater	  lymphoprolif-­‐erative	  responses	  and	  lower	  counts	  of	  senescent	  T	  cells.	  Taken	  together,	  these	  data	  suggest	   that	   immune	  system	  is	  plastic	  and	   immunosenescence	  can	  be	  attenuated	  psychoneuroendocrine	  interventions.	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Introduction	  Aging	  is	  associated	  with	  progressive	  changes	  in	  several	  key	  physiologi-­‐cal	  systems	   including	  the	   immune	  system,	  which	   is	  continuously	  remodeled	  over	  the	  life	  course,	  a	  process	  known	  as	  immunosenescence.	  Many	  age-­‐related	  diseases	  are	  directly	  associated	  with	  immunosenescence	  such	  as	  increased	  susceptibility	  to	  infectious	  diseases,	  neoplasias,	  metabolic	  diseases,	  osteoporosis	  and	  autoimmune	  diseases	  (Castle	  2000).	  Most,	  if	  not	  all,	  age-­‐related	  diseases	  have	  multifactorial	  eti-­‐ology	   including	   intrinsic	   (e.g.,	   genetic	   background)	   and	   extrinsic	   factors	   like	  health-­‐related	  behaviors	  and	  chronic	  stress	  exposure	  (Bauer	  2005).	  	  
The	  immunological	  changes	  observed	  during	  aging	  are	  found	  in	  similar	  magnitude	  following	  chronic	  stress	  or	  glucocorticoid	  exposure	  (reviewed	  in	  Bauer	  et	  al.	  2009).	  Indeed,	  the	  thymic	  involution	  and	  related	  drop	  in	  naïve	  T-­‐cell	  exports,	  increased	  memory	  and	  regulatory	  T	  cells,	  a	  Th1	  to	  Th2	  cytokine	  shift,	  reduced	  cell-­‐mediated	  immunity	  (e.g.	  blunted	  T-­‐cell	  proliferation),	  restricted	  TCRαβ	  repertoire	  in	   the	   CD4+	   and	   CD8+	   T	   cells,	   increased	   serum	   pro-­‐inflammatory	   markers	   (in-­‐flammaging)	  and	  shorter	  telomere	  lengths	  are	  all	  similar	  found	  during	  aging,	  dis-­‐tress	  conditions	  and	  chronic	  glucocorticoid	  exposure	  (Ramirez	  et	  al.	  1996;	  Wack	  et	  al.	  1998;	  Elenkov	  and	  Chrousos	  1999;	  Ashwell	  et	  al.	  2000;	  Franceschi	  et	  al.	  2000;	  Globerson	  and	  Effros	  2000;	  Sapolsky	  et	  al.	  2000a;	  Kiecolt-­‐Glaser	  et	  al.	  2003;	  Effros	  et	  al.	  2005;	  Hoglund	  et	  al.	  2006;	  Trzonkowski	  et	  al.	  2006;	  Damjanovic	  et	  al.	  2007;	  Sauce	  and	  Appay	  2011).	  Considering	  these	  multitude	  of	  determinants,	  efforts	  have	  been	  made	   to	   characterize	   immunosenescence	   from	  a	  multidisciplinary	  perspec-­‐tive	   as	  well	   as	   to	   design	   broad	   interventions	   to	   attenuate	   the	   effects	   age-­‐related	  immunological	   changes.	  This	   review	  will	   summarizes	   these	  approaches,	   by	  high-­‐
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lighting	  several	  key	  determinants	  of	  aging	  of	  the	  immune	  system	  as	  well	  as	  novel	  interventions	  aimed	  to	  mitigate	  its	  effects.	  
Stress	  factors	  as	  determinants	  of	  immunosenescence	  Healthy	   aging	   has	   been	   associated	  with	   significant	   psychological	   bur-­‐den	   (or	   distress).	   We	   have	   previously	   reported	   that	   strictly	   healthy	   elders	  (SENIEUR)	  were	   significantly	  more	   stressed,	   anxious	   and	   depressed	   than	   young	  adults	  (Luz	  et	  al.	  2003;	  Collaziol	  et	  al.	  2004).	  In	  accordance	  with	  increased	  psycho-­‐logical	  morbidity,	   the	   healthy	   elders	   had	   higher	   cortisol	   (45%)	   and	   lower	   dehy-­‐droepiandrosterone	   (DHEA,	   -­‐54%)	   levels	   compared	   to	   young	   adults	   (Luz	   et	   al.	  2003),	   indicating	   a	   neuroendocrine	   imbalance	   of	   the	   hypothalamic-­‐pituitary-­‐adrenal	   (HPA)	   axis.	   Increased	   cortisol	   levels	   were	   associated	   with	   a	   fall	   in	   the	  numbers	   of	   naïve	   T	   cells	   (Collaziol	   et	   al.	   2004)	   and	   reduced	   T	   cell	   proliferation	  (Luz	   et	   al.	   2006)	   during	   healthy	   aging.	   We	   argued	   that	   these	   neuroendocrine	  dysregulations	  may	   contribute	   to	   immunosenescence	   since	  all	   leukocytes	   exhibit	  receptors	  and	  are	  thus	  fully	  responsive	  for	  these	  neuroendocrine	  products.	  
However,	   healthy	   aging	   has	   been	   associated	  with	   reduced	   cellular	   re-­‐sponsiveness	   to	   glucocorticoids	   (GCs).	   The	   effects	   of	  GCs	   on	   the	   immune	   system	  are	  mediated	  via	  both	  intracellular	  and	  membrane	  GC	  receptors	  (GRs)	  (McEwen	  et	  al.	  1997).	  Healthy	  elders	  had	  a	  reduced	  (–19%)	   in	  vitro	   lymphocyte	  sensitivity	  to	  dexamethasone	  (a	  synthetic	  GC)	  compared	  to	  young	  adults	  (Luz	  et	  al.	  2003),	  sug-­‐gesting	  acquired	  resistance	  to	  GCs.	  We	  hypothesize	  that	  high	  cortisol	  levels	  render	  lymphocytes	  resistant	   to	  steroids,	   thus	  promoting	   inflammation	  and	  “inflammag-­‐ing”.	  A	  recent	  study	  support	  this	  hypothesis,	  reporting	  that	  higher	  immune	  gluco-­‐corticoid	   resistance	  was	   associated	  with	   greater	   pro-­‐inflammatory	   cytokine	   pro-­‐
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duction	   by	   cells	   of	   young	   adults	   infected	   with	   common	   cold	   virus	   (Cohen	   et	   al.	  2012).	   Taken	   together,	   these	   data	   show	   correlations	   between	   healthy	   aging,	   in-­‐creased	   psychological	   stress,	   activation	   of	   the	   HPA	   axis	   and	   specific	   immune	  changes	  characteristic	  of	  immunosenescence.	  	  
Chronic	  stress	  may	  lead	  to	  premature	  immunosenescence	  Superimposing	   chronic	   stress	   during	   aging	  might	   thus	   accelerate	   fea-­‐tures	  of	  immunosenescence.	  It	  is	  well	  known	  that	  chronic	  exposure	  to	  psychologi-­‐cal	   stress	   is	   correlated	  with	   suppressive	   immune	   functions	   (Reviewed	   in	   Glaser	  and	  Kiecolt-­‐Glaser	  2005).	  These	  associations	  may	  be	  explained	  by	  accelerate	  aging	  of	   several	   lymphoid	   organs	   and	   key	   immunological	   functions	   (Bauer	   2008).	  Stressed	  elders	  may	  thus	  be	  at	  risk	  for	  the	  development	  of	  stress-­‐related	  patholo-­‐gies	  because	  of	  detrimental	  additive	  effects	  of	  stress	  upon	   the	  aged	   immune	  sys-­‐tem.	  	  
Is	   there	   any	   elderly	   population	   especially	   at	   risk	   for	   premature	   im-­‐munosenescence?	   Elderly	   caregivers	   of	   spouses	   with	   dementia	   represent	   such	  model	  to	  study	  the	  superimposing	  (and	  detrimental)	  effects	  of	  chronic	  psychologi-­‐cal	  stress	  upon	   immunosenescence.	  Caregiving	   for	   the	   first-­‐grade	  elderly	  relative	  with	   dementia	   is	   an	   exceptionally	   demanding	   task	   associated	   with	   increased	  stress,	  anxiety,	  depression	  and	  notably	  suppressed	   immune	  functions	   (Redinbaugh 
et al. 1995).	  A	  longitudinal	  study	  has	  shown	  that	  caregivers	  had	  increased	  mortality	  rate	  (>63%)	  compared	  to	  non-­‐stressed	  controls	  (Schulz	  and	  Beach	  1999).	  Caregiv-­‐ing	  for	  a	  chronically	   ill	  partner	  (stroke	  or	  dementia)	   is	  associated	  with	   increased	  susceptibility	   to	   upper	   respiratory	   infections,	   including	   influenza	   (Vedhara	   et	   al.	  1999),	   and	   reduced	   immune	   responses	   to	   pneumococcal	   pneumonia	   vaccines	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(Glaser	   et	   al.	   2000).	   It	   has	   been	   shown	   that	   elderly	   caregivers	   of	   Alzheimer	   pa-­‐tients	  have	  impaired	  T	  cell	  proliferation	  (Bauer	  et	  al.	  2000),	  reduced	  NK	  cell	  activi-­‐ty	  (Esterling	  et	  al.	  1996),	  low	  salivary	  IgA	  levels	  (Gallagher	  et	  al.	  2008),	  a	  reduced	  IL-­‐2	  production	  (Bauer	  et	  al.	  2000)	  in	  contrast	  to	  higher	  TNF-­‐α,	  IL-­‐10	  (Damjanovic	  et	  al.	  2007)	  and	  IL-­‐6	   levels	  (Kiecolt-­‐Glaser	  et	  al.	  2003).	  Stress-­‐related	   increase	   in	  proinflammatory	   cytokines,	   such	   as	   TNF-­‐α	   and	   IL-­‐6,	   have	   broad	   health-­‐related	  implications,	  including:	  several	  age-­‐related	  conditions	  like	  cardiovascular	  diseases,	  osteoporosis,	  arthritis,	  type	  II	  diabetes,	  some	  neoplasias,	  periodontal	  disease,	  frail-­‐ty	  and	  functional	  decline	  (Harris	  et	  al.	  1999).	  Chronic	  psychological	  stress	  has	  been	  correlated	  with	  increased	  oxidative	  stress,	  reduced	  telomerase	  activity	  and	  shorter	  telomere	  length,	  suggesting	  a	  state	  of	  premature	  cell	  senescence,	  which	  could	  im-­‐plicated	  with	  reduced	  longevity	  (Epel	  et	  al.	  2004).	  
What	  are	  the	  potential	  mechanisms	  involved	  with	  stress-­‐related	  prema-­‐ture	  features	  of	  immunosenescence?	  There	  is	  evidence	  suggesting	  that	  neuroendo-­‐crine	   changes	   are	   responsible	   for	   such	   changes.	   Indeed,	  we	   have	   previously	   ob-­‐served	  that	  elderly	  caregivers	  of	  dementia	  spouses	  had	  significantly	  higher	  cortisol	  levels	   compared	   to	   non-­‐stressed	   elderly	   controls	   (Bauer	   et	   al.	   2000).	   Acquired	  steroid	  resistance	  was	  also	  demonstrated	  at	  the	  cellular	   level:	  caregivers	  showed	  increased	   lymphocyte	   GC	   resistance	   compared	   to	   non-­‐stressed	   elderly	   controls.	  Again,	  we	   hypothesize	   that	   high	   cortisol	   levels	  would	   render	   lymphocytes	  more	  resistant	  to	  steroids,	  further	  promoting	  “inflammaging”.	  
Taking	  together,	  chronic	  stress	  is	  involved	  in	  the	  premature	  dysregula-­‐tion	   of	   key	   allostatic	   systems	   associated	  with	   accelerated	   immunosenescence.	   It	  should	   be	   considered	   that	   other	   lifestyle	   factors,	   coping	   strategies	   and	   tempera-­‐
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ment	  may	  also	  influence	  the	  pace	  of	  immunosenescence.	  It	  is	  expected	  that	  stress-­‐management	   interventions	  would	   be	   beneficial	   for	   the	   elderly.	   The	   next	   section	  will	   review	   some	   interventions	   designed	   to	   reduce	   the	   impact	   of	   stress	   on	   im-­‐munosenescence.	  	  
Interventions	  aimed	  at	  attenuating	  immunosenescence	  
Psychosocial	  interventions	  Psychosocial	  interventions	  have	  been	  effective	  in	  attenuating	  stress	  and	  promoting	  a	  better	  endocrine	  balance	  in	  the	  elderly.	  By	  reducing	  stress	  levels	  and	  promoting	   healthy	   behaviors,	   psychosocial	   interventions	  may	   also	   attenuate	   the	  rise	  in	  cortisol,	  decline	  in	  DHEA,	  and	  promote	  enhanced	  vagal	  tone,	  possibly	  result-­‐ing	   in	   better	   immune	   responses.	   For	   example,	   following	   a	   psychological	   enrich-­‐ment	  program,	  elderly	  individuals	  showed	  increased	  levels	  of	  DHEA,	  testosterone,	  estradiol	   and	   growth	   hormone	   (GH)	   (Arnetz	   et	   al.	   1983).	   This	   psychological	   en-­‐richment	   program	   was	   designed	   to	   counteract	   social	   isolation	   and	   passivity	   by	  increasing	   social	   activation,	   competence,	   and	   independence.	   Another	   study	  showed	   that	  older	  adults	  who	  practiced	  relaxation	   techniques,	  had	  reduced	  anti-­‐body	   titers	   to	   latent	  Herpes	  Simplex	  virus-­‐1	   (HSV-­‐1).	  Lower	  viral	  antibody	   titers	  suggest	  fewer	  episodes	  of	  viral-­‐reactivation,	  indicating	  that	  a	  lifestyle	  intervention	  was	   associated	   with	   reduced	   chronic	   antigenic	   stimulation	   (Gouin	   et	   al.	   2008).	  These	  studies	  suggest	  that	  stress-­‐buffering	  strategies	  can	  lead	  to	  an	  improvement	  in	  cellular	  immunity	  involved	  in	  the	  control	  of	  latent	  viruses.	  	  
Resilience	  factors	  may	  also	  buffer	  the	  impact	  of	  stress	  on	  key	  allostatic	  systems	  (i.e.	  neuroendocrine	  and	  immune)	  of	  the	  elderly.	  Recent	  data	  produced	  by	  our	   laboratory	  have	  suggested	  that	   the	  maintenance	  of	  health	  during	  aging	  mini-­‐
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mizes	   the	   effects	   of	   chronic	   stress	   exposure	   (Jeckel	   et	   al.	   2010).	   We	   recruited	  chronically	  stressed	  and	  non-­‐stressed	  SENIEUR	  older	  adults	  and	  investigated	  neu-­‐roendocrine	  and	   immunological	   changes.	  The	  stressed	  group	   included	  caregivers	  of	  the	  first-­‐grade	  elderly	  relative	  with	  dementia.	  Despite	  elderly	  caregivers	  of	  de-­‐mentia	  patients	  were	   significantly	  more	   stressed	   than	  elderly	   controls	  without	   a	  caring	   burden,	   no	   changes	   in	   cortisol	   levels	  were	   observed.	   Positive	   neuroendo-­‐crine-­‐immune	  interactions	  (eustress)	  were	  also	  observed	  in	  these	  strictly	  healthy	  and	  stressed	  elders.	  Healthy	  elderly	  caregivers	  exhibited	  increased	  T	  cell	  prolifera-­‐tion	  and	  higher	  cellular	  sensitivity	  to	  GCs	  compared	  to	  non-­‐stressed	  healthy	  con-­‐trols.	  Elderly	  individuals	  engaged	  in	  physically	  active	  behaviors	  do	  not	  experience	  enhanced	   levels	   of	   emotional	   distress	   (Wrosch	   et	   al.	   2002)	   and	   have	   attenuated	  secretion	   of	   salivary	   cortisol	   (Wrosch	   et	   al.	   2007).	   A	   strong	   resilience	   factor	   for	  health	   outcomes	   may	   be	   the	   induction	   and	   maintenance	   of	   positive	   emotion	  through	   personality	   and	   coping	   styles.	   Individuals	   reporting	   personality-­‐type	   of	  positive	  affect	  have	  lower	  cortisol	  levels,	  reduced	  inflammatory	  markers	  (e.g.	  IL-­‐6,	  CRP)	  and	  favorable	  associations	  with	  heart	  rate	  and	  blood	  pressure	  (Steptoe	  et	  al.	  2009).	   In	   addition,	   stressed	   individuals	   with	   better	   social	   support	   had	   stronger	  immune	  responses	  to	  vaccination	  (Glaser	  et	  al.	  1992).	  Therefore,	  resilience	  factors	  or	   stress-­‐management	   interventions	   appear	   to	   be	   to	   modulate	   aspects	   of	   im-­‐munosenescence	  most	  likely	  by	  reducing	  endogenous	  GC	  levels.	  	  
DHEA	  supplementation	  DHEA	   and	   its	   metabolites	   have	   been	   considered	   the	   natural	   endoge-­‐nous	  antagonists	  of	  GCs	  (Hazeldine	  et	  al.	  2010).	  Serum	  DHEA	  levels	  decrease	  sig-­‐nificantly	   after	   the	   second	   decade	   of	   life	   in	   humans,	   and	   the	   elderly	   exhibit	   less	  than	   5%	   of	   the	   concentrations	   seen	   in	   younger	   adults	   (Hornsby	   1995).	   The	   im-­‐
9	  	  
paired	  DHEA	  secretion,	   in	  parallel	  with	  increased	  cortisol	   levels,	  results	  in	  an	  en-­‐hanced	  exposure	  of	   leukocytes	   to	  deleterious	  effects	  of	  GCs	   (Butcher	  et	  al.	  2005;	  Maninger	  et	  al.	  2009;	  Khanfer	  et	  al.	  2011).	  DHEA	  replacement	  therapy	  has	  yielded	  significant	   beneficial	   effects	   for	   healthy	   elders,	   including	   increased	   well-­‐being,	  memory	  performance,	  bone	  mineral	  density	  and	  altered	   immune	  function	  (Buvat	  2003;	  Nair	  et	  al.	  2006;	  Kenny	  et	  al.	  2010).	  DHEA	  replacement	  can	  increase	  glucose	  tolerance	  and	  reduce	   insulin	  resistance	   in	  elders	  (Weiss	  et	  al.	  2011).	   In	  addition,	  flattened	   DHEA	   diurnal	   profile	   has	   been	   associated	   with	   impaired	   physical	  function	  during	  aging	   (Heaney	  et	  al.	  2012).	  However,	  a	   recent	   systematic	   review	  indicated	   no	   conclusive	   evidence	   of	   benefits	   of	   DHEA	   replacement	   on	   muscle	  strength	   and	   physical	   function	   in	   clinical	   trials	   (Baker	   et	   al.	   2011)	   –	   with	   no	  recommendation	  for	  this	  use	  in	  the	  elderly.	  DHEA	  replacement	  may	  also	  have	  pro-­‐tective	   cardiovascular	   properties,	   as	   it	   can	   improve	   arterial	   stiffness	   index	   in	   el-­‐ders	  (Weiss	  et	  al.	  2012).	  While	  the	  DHEA	  replacement	  can	  induce	  similar	  changes	  in	  both	  men	  and	  women,	  in	  some	  cases	  the	  effects	  can	  be	  genre-­‐specifics,	  as	  DHEA	  replacement	  can	  improve	  the	  ovarian	  performance	  (Gleicher	  and	  Barad	  2011).	  
Previous	   studies	   have	   investigated	   the	   immunomodulatory	   effects	   of	  DHEA	   in	   vitro	   as	  well	   as	   following	   in	   vivo	   supplementation	   (Suzuki	   et	   al.	   1991).	  DHEA	  supplementation	  was	  associated	  with	   increased	  natural	  killer	   (NK)	   counts	  and	  cytotoxic	   function,	  as	  well	  as	  decreased	   IL-­‐6	  production	  and	  T-­‐cell	  prolifera-­‐tion	   in	   vitro,	   and	  with	   increased	   secretion	   of	   IL-­‐2	   by	   T	   cells	   (Suzuki	   et	   al.	   1991;	  Casson	   et	   al.	   1993;	   Di	   Santo	   et	   al.	   1996;	   Straub	   et	   al.	   1998;	   Solerte	   et	   al.	   1999;	  Hazeldine	  et	  al.	  2010).	  Although	  both	  T	  and	  B	  cells	  can	  be	  stimulated	  in	  vitro,	  they	  require	  different	  DHEA	  concentrations	  (Sakakura	  et	  al.	  2006).	  Because	  of	  its	  anti-­‐
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inflammatory	  properties,	  the	  potential	  benefits	  of	  DHEA	  have	  been	  investigated	  in	  autoimmune	   diseases.	   However,	   following	   encouraging	   studies	   demonstrating	  beneficial	  effects	  of	  DHEA	  supplementation	   in	  murine	   lupus	  models,	   the	  effect	  of	  DHEA	   on	   disease	   activity	   in	   lupus	   patients	   remains	   controversial	   (Sawalha	   and	  Kovats	   2008).	   Previous	   studies	   have	   also	   explored	   the	   potential	   use	   of	  DHEA	   as	  adjuvant	   in	   vaccine	   preparations.	   Notwithstanding	   the	   clear	   adjuvant	   effects	   of	  DHEA	   during	   immunization	   to	   hepatitis	   B	   (Araneo	   et	   al.	   1993)	   or	   influenza	  (Danenberg	  et	  al.	  1995)	  in	  mice,	  negative	  effects	  have	  been	  reported	  following	  in-­‐fluenza	  vaccination	  in	  older	  humans	  (Danenberg	  et	  al.	  1997;	  Degelau	  et	  al.	  1997).	  	  
Overall,	   these	   data	   indicate	   the	   potential	   use	   of	   DHEA	   as	   anti-­‐aging	  hormone	   and	   suggest	   that	   DHEA	   supplementation	  might	   attenuate	   chronic	   low-­‐grade	   inflammation	   and	   age-­‐related	   frailty	   by	   inhibiting	   production	   of	   pro-­‐inflammatory	  cytokines.	  It	  should	  be	  kept	  in	  mind	  that	  very	  few	  data	  exist	  regard-­‐ing	  the	  DHEA	  effects	  on	  the	  immune	  responses	  of	  the	  elderly	  and	  large	  clinical	  tri-­‐als	  are	  thus	  necessary	  to	  disentangle	  conflicting	  reports.	  Some	  studies	  have	  found	  mild	  adverse	  effects	  in	  the	  study	  subjects,	  who	  had	  acne	  and	  hirsutism	  in	  general.	  A	   recent	   study	   reported	   that	   higher	   DHEA-­‐S	   levels	   were	   associated	   with	  depressive	  symptoms,	  but	  not	  diagnosis	  of	  major	  depression,	  during	  menopausal	  transition	  (Morrison	  et	  al.	  2011).	  Importantly,	  pharmacological	  DHEA	  levels	  have	  been	  associated	  with	   the	  development	  of	  hepatocellular	  carcinoma	  (Hazeldine	  et	  al.	  2010).	  	  
Melatonin	  treatment	  Melatonin	   supplementation	   could	   be	   of	   potential	   value	   for	   elders	   due	  its	   antagonistic	   effects	   on	   cortisol	   (Maestroni	   et	   al.	   1986),	   as	  well	   as	   potentially	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enhancing	  effects	  of	  cell-­‐mediated	   immunity.	  The	  production	  of	  melatonin	  by	  the	  pineal	  gland	  begins	  as	  the	  eyes	  close	  and	  its	  secretion	  is	  associated	  with	  serotonin	  production,	   which	   is	   activated	   during	   the	   dark	   cycle.	  Furthermore,	   melatonin	   is	  also	  secreted	  by	  several	  leukocytes	  including	  monocytes,	  T	  and	  NK	  cells	  and	  mast	  cells	  (Hardeland	  et	  al.	  2011).	  Similar	  to	  cortisol,	  melatonin	  secretion	  has	  a	  circadi-­‐an	   rhythm.	  The	  peak	   secretion	  occurs	   at	   night	   and	   very	   low	   levels	   are	   observed	  upon	  waking	  in	  the	  morning.	  Importantly,	  melatonin	  is	  reduced	  in	  elderly	  individ-­‐uals,	   together	   with	   a	   decrease	   in	   the	   amplitude	   of	   the	   circadian	   rhythm	   of	   this	  hormone	  (Bastien	  et	  al.	  2003).	  Although	  the	  age-­‐related	  reduction	  of	  the	  melatonin	  levels	   is	  considered	  as	  a	  predisposing	  factor	  for	  neurodegenerative	  diseases	  such	  as	   Alzheimer's,	   melatonin	   replacement	   therapy	   may	   have	   neuroprotective	  potential	  (Srinivasan	  et	  al.	  2006;	  Cardinali	  et	  al.	  2008;	  Markus	  et	  al.	  2010).	  	  
The	  decline	  in	  melatonin	  levels	  during	  aging	  has	  been	  proposed	  to	  play	  an	   important	  role	   in	   immunosenescence	  (Cardinali	  et	  al.	  2008).	   In	  addition	  to	   its	  sleep	  regulatory	  properties,	  melatonin	  is	  a	  natural	  antioxidant	  with	  important	  im-­‐munological	   properties.	   The	   immunomodulatory	   properties	   of	  melatonin	   are	   re-­‐lated	  in	  part	  to	  its	  actions	  on	  specific	  membrane	  (MT1	  and	  MT2)	  or	  nuclear	  recep-­‐tors	  located	  in	  leukocytes.	  The	  in	  vitro	  effects	  of	  melatonin	  include	  increased	  T	  cell	  proliferation	   (Konakchieva	   et	   al.	   1995)	   enhancement	   of	   NK	   cell	   cytotoxicity	  (Currier	  et	  al.	  2000)	  and	  increased	  production	  of	  several	  cytokines	  including	  IL-­‐1,	  IL-­‐2,	   IL-­‐12,	   IL-­‐6,	  TNF-­‐α	  and	  IFN-­‐γ	   (Garcia-­‐Maurino	  et	  al.	  1997;	  Garcia-­‐Maurino	  et	  al.	  1999;	  Chen	  and	  Wei	  2002).	  Conversely,	  melatonin	  has	  anti-­‐inflammatory	  prop-­‐erties	   including	   inhibition	   of	   NO	   synthases	   and	   5-­‐lipoxygenase	   (Hardeland	   et	   al.	  2011).	  A	  recent	  in	  vitro	  study	  with	  human	  T-­‐cell	  lines	  demonstrated	  that	  melatonin	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efficiently	  downregulates	   the	  expression	  of	   retinoic	  acid-­‐related	  orphan	  receptor	  alpha	  (RORα),	  a	  key	  transcription	  factor	  involved	  with	  differentiation	  of	  Th17	  and	  regulatory	  T	  cells	  (Tregs)	  (Lardone	  et	  al.	  2011).	  Melatonin	  also	  stimulates	  the	  pro-­‐duction	  of	  glutathione,	  the	  most	  abundant	  antioxidant	  molecule	  found	  in	  mamma-­‐lian	  cells.	  Aside	  from	  detoxifying	  hydrogen	  peroxide	  into	  water,	  glutathione	  is	  also	  essential	  for	  lymphocyte	  activation,	  proliferation	  and	  cytotoxicity	  (Suthanthiran	  et	  al.	  1990;	  Liang	  et	  al.	  1991).	  Thus,	  the	  immune-­‐enhancing	  properties	  of	  melatonin	  may	  be	  in	  part	  due	  to	  maintenance	  of	  intracellular	  glutathione	  levels,	  and	  the	  sub-­‐sequent	  effects	  on	  cell-­‐mediated	  immunity	  (Cardinali	  et	  al.	  2008).	  In	  support,	  mel-­‐atonin	  administration	  increased	  the	  total	  number	  of	  thymocytes	  in	  old	  mice	  (Tian	  et	  al.	  2003).	  This	  protective	  effect	  of	  melatonin	  on	  thymocytes	  was	  attributed	  to	  its	  anti-­‐apoptotic	   action,	   by	   inhibiting	   GC-­‐induced	   thymic	   apoptosis.	   Melatonin	   re-­‐placement	  has	  been	  effective	   in	  suppressing	  neoplastic	  growth	   in	  a	  variety	  of	   tu-­‐mors,	  including	  breast	  and	  prostate	  cancer,	  melanoma,	  ovarian	  and	  colorectal	  can-­‐cer	  (Srinivasan	  et	  al.	  2011).	  Melatonin	  showed	  beneficial	  effects	  in	  adjuvant	  thera-­‐py	  aimed	  to	  treat	  patients	  suffering	  from	  breast	  cancer,	  hepatocellular	  carcinoma	  or	  melanoma	   (Srinivasan	   et	   al.	   2011).	  Although	   there	   are	  many	   studies	   showing	  the	   immunomodulatory	  properties	   of	  melatonin,	   there	   is	   a	   lack	   of	   investigations	  relevant	   to	   immunosenescence.	   However,	   the	   side-­‐effects	   of	   melatonin	   replace-­‐ment	   have	   been	   reported	   (e.g.	   daytime	   sleepiness,	   dizziness,	   headaches	   and	  interaction	  with	  others	  medications	   like	  anticoagulants	  and	   immunosupressants)	  and	  should	  be	  considered	  during	  long-­‐term	  treatment.	  
GH	  and	  ghrelin	  replacement	  therapies	  Aging	   significantly	   reduces	   pituitary	  GH	   levels,	   a	   phenomenon	   known	  as	  somatosenescence.	  The	  absence	  of	  appropriate	  GH-­‐immune	  signaling	  may	  also	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accelerate	  immunosenescence.	  GH-­‐deficient	  mice	  exhibit	  immune	  dysfunction	  (in-­‐cluding	   thymic	   involution),	   which	   can	   be	   reversed	  with	   GH	   replacement	   (Kelley	  1990).	  Indeed,	  GH	  has	  many	  direct	  (or	  indirect	  effects	  via	  induction	  of	  IGF-­‐1)	  im-­‐munoregulatory	  effects.	  For	  example,	  GH	  may	  enhance	  lymphocyte	  cytotoxicity	  (in	  both	  CD8+	  T	   cells	   and	  NK	   cells),	   increase	   lymphocyte	   proliferation,	   promote	   the	  differentiation	  of	  neutrophils,	  as	  well	  as	  increase	  TNF-­‐α	  and	  thymulin	  production	  (Welniak	   et	   al.	   2002).	   	   The	   GH	   replacement	   in	   older	   subjects	   may	   not	   only	  modulate	   the	   levels	   of	   IGFs	   and	   IGFBPs	   but	   also	   with	   little	   gender-­‐related	  differences	  (i.e.	  increase	  of	  IGF-­‐1	  and	  IGFBP	  -­‐3	  in	  both	  sexes;	  IGFBP-­‐2	  and	  IGFBP-­‐5	  increase	   only	   in	   men	   and	   immunoreactive	   insulin	   increase	   only	   in	   women)	  (Munzer	  et	  al.	  2006).	  However,	  men	  may	  have	  a	  better	  response	  (IGF-­‐1	  levels)	  to	  GH	  replacement	  than	  women	  (Gotherstrom	  et	  al.	  2007).	  The	  replacement	  can	  also	  increase	  the	  protein	  synthesis	  in	  elderly	  people,	  this	  effect	  is	  stronger	  in	  men	  when	  GH	  replacement	  is	  carried	  along	  with	  testosterone	  (Huang	  et	  al.	  2005).	  In	  addition,	  GH	  is	  synthesized	  by	  leukocytes,	  mimics	  the	  action	  of	  IFN-­‐γ,	  increasing	  the	  activity	  of	  phagocytes	  (Kelley	  1990).	  GH	  replacement	  therapy	  may	  be	  of	  clinical	  value	  by	  restoring	  immune	  competence	   in	  the	  elderly.	  However	  side	  effects	  of	  GH	  therapy	  also	  exist.	  For	  instance,	  GH	  administration	  could	  reduce	  the	  levels	  of	  sex	  hormones,	  promoting	  secondary	  changes	  in	  the	  immune	  system,	  obesity	  and	  even	  cancer	  (Lo	  et	  al.	  2001).	  	  
Considering	   patients	   with	   GH	   deficiency,	   the	   replacement	   has	   shown	  beneficial	   effects	   to	   the	   thymus	   and	   to	   the	   T-­‐cell	   proliferation	   as	   well	   as	   bone	  mineral	   density,	   which	   reinforces	   the	   concept	   that	   GH	   is	   capable	   to	   attenuate	  senescence	  (Morrhaye	  et	  al.	  2009;	  Elbornsson	  et	  al.	  2012).	  Furthermore,	  we	  have	  
14	  	  
previously	  observed	  that	  low	  pituitary	  GH	  levels	  were	  not	  associated	  with	  a	  recip-­‐rocal	  decline	  in	  immunoreactive	  GH	  produced	  by	  lymphocytes	  during	  human	  aging	  (Luz	  et	  al.	  2006).	  The	  potential	  side-­‐effects	  of	   long-­‐term	  GH	  replacement	  shall	  be	  considered,	   and	   include	   carpal	   tunnel	   syndrome,	   arthralgia,	   increased	   risk	   for	  diabetes	   (as	   it	   increases	   insulin	   resistance)	   and	   it	   has	   been	   associated	   with	  increased	  risk	  for	  Hodkin’s	  lymphoma	  (Freedman	  et	  al.	  2005).	  
Reduced	  ghrelin	  levels	  during	  aging	  may	  also	  contribute	  to	  immunose-­‐nescence.	  Ghrelin	  binds	  to	  a	  GH	  secretagogue	  receptor	  (GHS-­‐R)	  expressed	  on	  lym-­‐phoid	  cells,	  having	  anti-­‐inflammatory	  effects	  (lowering	  TNF-­‐α,	  IL-­‐1	  and	  IL-­‐6	  levels)	  (Dixit	   et	   al.	  2004).	  Ghrelin	   is	  produced	  by	   stomach	  cell,	  which	  modulates	  energy	  balance,	   stimulating	   appetite	   and	   pituitary	   GH	   secretion.	   Ghrelin	  may	   be	   an	   im-­‐portant	  factor	  for	  thymopoiesis	  during	  aging	  as	  mice	  deficient	  for	  ghrelin	  or	  GHS-­‐R	  showed	  profound	  age-­‐related	   thymic	   involution.	   In	  contrast,	  ghrelin	  replacement	  in	  old	  mice	  is	  associated	  with	  increased	  thymic	  mass,	  and	  a	  greater	  production	  of	  recent	   thymic	   emigrants	   with	   enhanced	   TCR	   diversity	   (Dixit	   et	   al.	   2007).	   The	  ghrelin	  replacement	  can	  increase	  the	  GH	  secretion	  in	  elders	  (Nass	  et	  al.	  2008),	  	  and	  can	  also	  help	  to	  increase	  the	  bone	  mineral	  density	  in	  women	  (Napoli	  et	  al.	  2011).	  Cytokine	  replacement	  could	  be	  also	  of	  interest	  in	  rejuvenating	  thymopoiesis	  and	  T-­‐cell	  function.	  Sportés	  et	  al.	  have	  recently	  shown	  that	  IL-­‐7	  can	  rejuvenate	  the	  aging	  immune	  system	  in	  humans	  by	  promoting	  thymopoiesis	  (increasing	  the	  numbers	  of	  naïve	  T	  cells)	  and	  expanding	  TCR	  repertoire	  diversity	  (Sportes	  et	  al.	  2008).	  In	  ad-­‐dition,	  it	  was	  shown	  that	  treatment	  with	  thymosin	  α1	  (Tα1)	  resulted	  in	  increased	  T-­‐cell	  responses	  (e.g.,	  cytokine	  production,	  proliferation	  and	  cytotoxicity).	  Tα1	  is	  a	  28-­‐amino	  acid	  biologically	  active	  protein	  that	  has	  pharmacologic	  effects	  enhancing	  
15	  	  
cellular	   immunity.	   Tα1	   administration	  was	   highly	   effective	   in	   the	   restoration	   of	  cell-­‐mediated	   functions	   when	   used	   in	   combination	  with	   cytokines	   (Naylor	   et	   al.	  2007).	  	  However,	  the	  long-­‐term	  beneficial	  effects	  of	  ghrelin	  replacement	  therapies	  should	   be	   considered	   with	   caution	   as	   it	   can	   be	   pro-­‐oncogenic	   (Akamizu	   and	  Kangawa	  2012).	  	  	  
Regular	   moderate-­‐intensity	   physical	   activity	   is	   associated	   with	   better	  
immune	  responses	  Physical	   activity	   is	   associated	  with	  many	  beneficial	  health	  effects,	   and	  has	  the	  advantage	  of	  being	  a	  non-­‐invasive,	  low-­‐cost	  and	  easy	  to	  implement	  therapy	  or	   intervention.	   Interventions	   including	   health	   behavior	   changes	   are	   likely	   to	   be	  more	  effective	   in	  attenuating	  aging	  of	   the	   immune	  system.	   Indeed,	   increasing	   fit-­‐ness	   is	   probably	   one	   of	   the	   most	   powerful	   interventions	   in	   restoring	   corti-­‐sol/DHEA	   balance	   and	   can	   improve	   psychological	   and	   physiological	   well-­‐being.	  Long-­‐term	  moderate-­‐intensity	  exercise	   can	  decrease	  cortisol	  and	   increase	  DHEA,	  GH	   and	   IGF-­‐1	   levels	   (Cotman	   and	   Berchtold	   2002),	   as	   well	   as	   reduced	   anxiety	  (Petruzzello	  et	  al.	  1991)	  and	  depression	  (Barbour	  et	  al.	  2007).	  
Moderate-­‐intensity	   exercise	   has	   been	   associated	   with	   anti-­‐inflammatory	  effects,	  including	  lowering	  serum	  TNF-­‐α,	  IL-­‐6	  levels	  and	  higher	  IL-­‐10	  and	  Treg	  counts	  (Gleeson	  et	  al.	  2011).	  These	  effects	  might	  be	  mediated	  by	  the	  re-­‐duction	   of	   visceral	   fat	  mass	   and	   correlated	   decreased	   released	   of	   adipokines,	   as	  well	  as	  the	  induction	  of	  the	  anti-­‐inflammatory	  environment	  promoted	  by	  the	  mod-­‐erate-­‐intensity	   exercise.	   In	   addition,	   moderate-­‐intensity	   exercise	   training	   in	   the	  elderly	  can	  also	  increase	  T-­‐cell	  proliferation,	  reduced	  the	  frequency	  of	  senescent	  T-­‐cells	   (i.e.	   CD45RO+,	  KLRG1+,	  CD57+,	  CD28-­‐),	   enhance	   IL-­‐2	  production	  and	  T-­‐cell	  expression	  of	  the	  IL-­‐2	  receptor,	  and	  is	  associated	  with	  longer	  leukocyte	  telomeres	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and	  better	  in	  vivo	  immune	  responses	  to	  vaccines	  and	  recall	  antigens	  (Simpson	  and	  Guy	  2010).	  Ogawa	  and	  col.	   compared	   the	  Th1/Th2	  cytokines	   in	  active	  vs.	   seden-­‐tary	  elderly,	  and	  observed	  greater	  numbers	  of	  IL-­‐2	  secreting	  CD8+	  cells	   in	  physi-­‐cally	   active	   elderly	   compared	   to	   those	  who	  were	   sedentary	   (Ogawa	   et	   al.	   2003).	  Enhanced	  T-­‐cell	   responses	  may	  be	  associated	  with	   stronger	   immunity	   to	   control	  viral	   and	   bacterial	   infections:	   It	   has	   been	   reported	   that	   physically	   active	   elderly	  women	  have	  a	  lower	  risk	  of	  community-­‐acquired	  pneumonia	  compared	  to	  seden-­‐tary	  elderly	  women	  (Baik	  et	  al.	  2000).	  On	  the	  other	  hand,	  a	  lack	  of	  regular	  exercise	  is	  associated	  with	  an	  increased	  the	  risk	  of	  hospitalization	  due	  to	  infection	  (Leveille	  et	  al.	  2000).	  This	  concept	  concurs	  with	  another	  study	  suggesting	  that	  physical	  ac-­‐tivity	   may	   increase	   mucosal	   immune	   responses	   in	   the	   elderly,	   promoting	   re-­‐sistance	  to	  upper	  respiratory	  infections	  (Sakamoto	  et	  al.	  2009).	  
Moderate-­‐intensity	   exercise	   also	   appears	   to	   buffer	   the	   age-­‐related	   in-­‐crease	   in	   pro-­‐inflammatory	   cytokines	   via	   epigenetic	  modifications.	   For	   instance,	  the	  methylation	  of	  the	  pro-­‐inflammatory	  ASC	  gene,	  involved	  in	  the	  secretion	  of	  IL-­‐1	  and	  IL-­‐18,	  reduced	  significantly	  with	  age,	  suggesting	  an	  age-­‐related	   increase	   in	  ASC	  expression	  (McGee	  et	  al.	  2009).	  Of	  particular	  note,	  the	  ASC	  methylation	  levels	  were	  higher	  in	  the	  older	  exercise	  group	  than	  in	  the	  older	  controls.	  To	  what	  extent	  these	  changes	  are	  related	  to	  cortisol/DHEA	  balance	  induced	  by	  moderate-­‐intensity	  exercise	  is	  largely	  unknown.	  
Conclusions	  and	  future	  perspectives	  Normal	   aging	   is	   associated	   with	   major	   changes	   in	   key	   allostatic	   sys-­‐tems,	  notably	   immune	  and	  neuroendocrine,	   that	   increase	   the	  risk	   for	  age-­‐related	  diseases.	  These	  effects	  do	  not	  appear	  driven	  by	  reverse	  causality	  (i.e.,	  an	  effect	  of	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age-­‐related	  health	   impairments	  on	   immunity),	  as	  healthy	  aging	   is	  also	  associated	  with	  significant	  psychological	  distress	  and	  HPA	  axis	  activation	  (increased	  cortisol	  and	  reduced	  DHEA	  levels).	  	  Although	  the	  exact	  mechanisms	  of	  immunosenescence	  remain	   to	   be	   elucidated,	   it	   is	   becoming	   apparent	   that	  many	   of	   the	  physiological	  changes	  associated	   with	   aging	   are	   characterized	   by	   epigenetic	   modifications	  (Fraga	  and	  Esteller	  2007).	  	  
We	   reviewed	   here	   that	   psychological	   or	   pharmacological	   strategies	  aimed	  to	  attenuate	  or	  prevent	  the	  increase	  in	  HPA	  axis	  activation	  with	  aging	  may	  benefit	   the	   elderly.	  Many	   studies	   aimed	   to	   understand	   how	   lifestyle	   factors	   pro-­‐mote	   or	   maintain	   good	   health.	   In	   this	   scenario,	   for	   instance,	   regular	   moderate-­‐intensity	  physical	  activity	  may	  help	  to	  delay	  the	  onset	  of	  immunosenescence.	  Some	  clinical	  strategies,	  such	  as	  hormone	  replacement	  or	  cytokine	  therapy	  may	  be	  useful	  to	   attenuate	   immunosenescence.	   However,	   the	   potential	   harmful	   side-­‐effects	   of	  prolonged	  hormonal	  supplementation	  shall	  be	  also	  considered.	  	  
The	  concept	  of	  hormesis	  should	  be	  discussed	  here	  considering	  the	  ge-­‐netic,	   hormonal	   and	   lifestyle	   factors	   involved	   in	   accelerating	   or	   buffering	   im-­‐munosenescence.	  Aging,	   senescence	   and	  death	   are	   the	   final	   consequences	   of	   im-­‐paired	   homeostasis	   or	   failure	   of	   homeodynamics	   (Rattan	   2006).	   The	   most	   im-­‐portant	  component	  of	  homeodynamics	  is	  represented	  by	  the	  capacity	  of	  living	  sys-­‐tems	   to	   deal	   (cope)	   with	   stress.	   A	   progressive	   shrinking	   of	   the	   homeodynamic	  space	  (or	  buffering	  capacity)	  is	  the	  hallmark	  of	  aging	  and	  strongly	  associated	  with	  age-­‐related	   diseases	   (Rattan	   2008).	   The	   stress	   responses	   in	   mammals	   include	  apoptosis,	   inflammation,	   and	   increased	  glucocorticoids	  –	   that	  are	  also	  associated	  with	   healthy	   aging.	   The	   clinical	   consequences	   of	   stress	   responses	   can	   be	   both	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harmful	   and	   beneficial,	   depending	   on	   characteristics	   of	   the	   stressor	   (Calabrese	  2008).	   This	   phenomenon	   of	   biphasic	   dose	   response	   was	   termed	   hormesis	  (Southam	  and	  Ehrlich	  1943)	  and	  it	  has	  been	  described	  across	  different	  disciplines	  including	   toxicology,	   pharmacology,	  medicine,	   radiation	   biology	   and	   gerontology	  (Calabrese	  et	  al.	  2012).	  A	  good	  example	  of	  stress-­‐induced	  hormesis	   is	  the	  benefi-­‐cial	  effects	  of	  moderate	  exercise	  (hormetic	  agent)	  to	  increase	  immunity	  and	  lower	  levels	  of	  oxidative	  stress	  (Radak	  et	  al.	  2008).	  Physical	  inactivity	  or	  overtraining	  are	  associated	   with	   damaging	   oxidative	   stress	   and	   blunted	   immune	   responses.	   Fur-­‐thermore,	  acute	  or	  mild	  stress	  is	  generally	  associated	  with	  enhanced	  immune	  func-­‐tions	   (Dhabhar	   and	  McEwen	   1999),	   which	   prepare	   the	   organism	   to	   better	   cope	  with	   the	  stressor.	   In	   contrast,	   chronic	   stress,	  which	   is	  not	   resolved	  via	  coping	  or	  adaptation,	  is	  considered	  to	  be	  distress	  and	  it	  has	  been	  associated	  with	  suppressed	  immune	   functions	   (Glaser	   and	   Kiecolt-­‐Glaser	   2005)	   and	   inflammation	   (Kiecolt-­‐Glaser	  et	  al.	  2003).	  These	  effects	  are	  related	  to	  GC	  concentration	  and	  to	  duration	  of	  tissue	   exposure	   to	   peripheral	  GCs.	   For	   instance,	   low	   cortisol	   levels	   produce	  per-­‐missive	  or	  stimulatory	  immune	  changes	  whereas	  long-­‐term	  or	  high	  cortisol	  levels	  are	   immunosuppressive	   (Sapolsky	   et	   al.	   2000b).	  Hormetic	   stressors	   (hormetins)	  can	   be	   applied	   successfully	   to	   interventions	   in	   aging	   and	   can	   be	   categorized	   as	  physical,	   nutritional,	   or	   psychological	   hormentins	   (Rattan	  2008).	  Moderate	   exer-­‐cise,	   hormonal	   and	   nutritional	   supplementation,	   and	   psychosocial	   interventions	  are	  good	  examples	  of	   stress-­‐induced	  hormesis	   aimed	   to	   improve	  homeodynamic	  space	  in	  aging.	  Recent	  studies	  suggest	  that	  lifestyle	  factors	  (such	  as	  physical	  activi-­‐ty)	  and	  human	  health	  may	  be	  linked	  through	  epigenetic	  mechanisms	  such	  as	  DNA	  methylation,	   histone	  modifications	   and	  micro-­‐RNAs	   (Sanchis-­‐Gomar	   et	   al.	   2012).	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Therefore,	   by	   favoring	   hormesis,	   the	   interventions	   reviewed	   here	   would	   render	  epigenetic	  changes	  involved	  with	  the	  attenuation	  of	  immunosenescence.	  
In	   comparison	   to	   younger	   adults,	   the	   elderly	   who	   are	   chronically	  stressed	  may	   be	   at	   a	   greater	   risk	   of	   stress-­‐related	   pathologies.	   Therefore,	   stress	  management	  and	  psychosocial	  support	  should	  promote	  a	  better	  quality	  of	  life	  for	  the	  elderly	  as	  well	  as	  reducing	  hospitalization	  costs.	  Preliminary	  evidence	  suggests	  that	  differences	   in	  personality	   traits	   (temperament)	  and	  coping	  skills	   could	  have	  protective	  properties.	  Finally,	  the	  maintenance	  of	  regular	  moderate-­‐intensity	  phys-­‐ical	  activity,	  social	  support,	  personality	  (positive	  affect)	  and	  coping	  skills	  may	  pro-­‐tect	  the	  elderly	  from	  the	  detrimental	  effects	  of	  chronic	  stress	  exposure.	  More	  stud-­‐ies	  are	  needed	  to	  address	  the	  relationships	  of	  health-­‐related	  behaviors	  on	  immuni-­‐ty	  that	  might	  promote	  better	  resilience	  to	  stress	  exposure.	  	  
This	  review	  has	  presented	  current	  evidence	  that	  it	  is	  possible	  to	  atten-­‐uate	   and	   potentially	   reverse	   many	   features	   of	   immunosenescence	   via	   stress-­‐management	   therapies,	   improved	   health-­‐related	   behaviors,	   and	   hormone	   re-­‐placement	   therapies.	  	  Low-­‐cost	  practices,	  such	  as	  moderate	  regular	  exercise,	  may	  also	  allow	  us	  to	  age	  healthily	  by	  attenuating	  the	  effects	  of	  immunosenescence.	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Figure Legend 	  Figure	  1.	  Some	  interventions	  aimed	  at	  attenuating	  immunosenescence.	  Hormonal	  replacement	   therapies	   have	   been	   effective	   to	   reduce	   inflammaging	   and	   improve	  several	  thymic-­‐related	  functions	  such	  as	  higher	  cellularity	  and	  T-­‐cell	  proliferation,	  cytokine	   production,	   and	   T-­‐cell	   repertoire	   (TCR)	   diversity.	   However,	   the	   side-­‐effects	  of	  long-­‐term	  hormonal	  therapies	  should	  be	  considered.	  Stress-­‐management	  and	  regular	  physical	  exercise	  have	  also	  been	  shown	   to	   reduce	   inflammaging	  and	  improve	   T-­‐cell	   functions	   most	   likely	   via	   increasing	   DHEA	   and	   reducing	   cortisol	  levels	  as	  well	  as	  via	  epigenetic	  modifications.	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